logo
How to watch new ITV documentary on British contaminated blood scandal

How to watch new ITV documentary on British contaminated blood scandal

Yahoo20-05-2025
A new ITV documentary relating to the British contaminated blood scandal will be airing tonight (Tuesday, May 20).
The British Blood Scandal: Poisoned at School focuses on the stories of haemophiliac children at the Lord Mayor Treloar School in Hampshire.
They were sent to the specialist boarding school with the promise of a 'normal childhood', but instead became victims of secret medical research which left many of them with Hepatitis and HIV.
A summary on the Radio Times website adds: "Revealing the true stories of the students of The Lord Mayor Treloar School and Hospital, a place where young haemophiliacs were given Factor VIII, a drug they thought was a cure but was actually a death sentence.
"Through deeply personal testimony, this documentary pieces together a story of secret clinical trials, medical negligence and the fight for truth at the heart of the worst medical disaster in NHS history."
Of the 122 haemophiliacs who attended Treloar's in the 1970s and 1980s, only around 30 are still alive today.
Jo Clinton-Davis, Controller of Factual ITV, said: 'As they continue their fight for justice, the raw truth of how thousands were affected by the 1970s and 1980s infected blood scandal is told by some of the last remaining victims themselves in this emotional documentary.
"It's shocking how these men have suffered all these years from something that was covered up and could have been prevented.'
Our next film 'The British Blood Scandal: Poisoned at School' is coming to ITV and ITVX at 9pm on the 20th of May! Read about it on our website here - https://t.co/82QPElneS5 pic.twitter.com/rTseug9DTK
— Candour Productions (@CandourTV) May 16, 2025
Anna Hall, Executive Producer at Candour Productions, said: 'The British Blood Scandal: Poisoned at School shows the devastating effect first-hand of a lifetime spent unearthing what happened to our survivors when they were just children.
"We are so humbled to have worked with the four men in this film who wanted to make this in honour of their school friends who died, so that the truth would finally be told.'
As reported by BBC News, in the 1970s and 1980s, more than 30,000 people in the UK were infected with HIV and hepatitis C after being given contaminated blood products.
One group that was impacted by this were haemophiliacs, who had rare disorders which meant their blood didn't clot properly.
Set your reminders, Tuesday 20th May ITV 9pm (Also available to stream on ITV X) The British Blood Scandal: Poisoned at School 💔💛🖤@chriswardmp @metpoliceuk @sussex_police @HaemoSocUK @UN @EHC_Haemophilia @wfhemophilia @ukhomeoffice @YvetteCooperMP @MoJGovUK @wesstreeting pic.twitter.com/3rDObtQSUg
— Mark Antony Ward (@Haemosexual) May 14, 2025
In the 1970s, a new treatment using donated human blood plasma was developed to replace clotting agents in haemophiliacs, but entire batches were contaminated with deadly viruses.
An inquiry found that about 1,250 people in the UK with bleeding disorders went on to develop both HIV and hepatitis C, including 380 children.
About two-thirds later died of Aids-related illnesses, with some unintentionally passing it onto their partners.
Recommended reading:
ITV to release documentary about infected blood scandal featuring victims' stories
Which blood type is the rarest? How to find out your blood type
The best exercise to lower your blood pressure according to new study
Another 2,400 to 5,000 people developed hepatitis C on its own, which can cause cirrhosis and liver cancer.
BBC News adds: "It is difficult to know the exact number of people infected with hepatitis C, partly because it can take decades for symptoms to appear."
A second group of patients were given contaminated blood transfusions after childbirth, surgery or other medical treatment between 1970 and 1991.
In total, it is thought around 3,000 people have died due to the infected blood scandal.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Abbott lowers sales forecast on diagnostics decline, US funding cuts
Abbott lowers sales forecast on diagnostics decline, US funding cuts

Yahoo

time4 hours ago

  • Yahoo

Abbott lowers sales forecast on diagnostics decline, US funding cuts

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers Q2 revenue: $11.14 billion 7.4% increase year over year Medical device sales: $5.37 billion 13.4% increase year over year Diagnostics sales: $2.17 billion 1% decrease year over year Abbott lowered its sales forecast for the year, citing a drop in diagnostic testing. CEO Robert Ford told investors on Thursday that the company is seeing a drop-off in COVID-19 testing sales, challenges in China's core laboratory market and a reduction in U.S. foreign aid funding for HIV testing, with a combined impact of more than $1 billion. The company reduced its 2025 organic sales growth forecast to a range of 6% to 7%, from the previous forecast of 7.5% to 8.5% shared in the first quarter. 'Even with that billion dollars, we're still forecasting high single-digit growth and absorbing the impact of tariffs,' Ford said. The company now expects 'just under $200 million' of impact from tariffs. CFO Phil Boudreau said the amount was down from previous estimates, when the company had outlined 'a few hundred million' in tariff costs. Discussing how the company plans to mitigate tariffs, Ford said that Abbott plans to open a new cardiovascular manufacturing facility in Georgia in 2028. 'Once tariffs get set in place, they're very difficult to walk away from,' the CEO said, 'so we have to think medium term, but also long term.' Growth in medical devices, diabetes A bright spot for Abbott was its medical device segment, which grew by more than 13% to $5.37 billion in sales. The company's diabetes segment grew by more than 20% to $1.98 billion. Analysts asked about Abbott's plans for a dual analyte sensor that would provide glucose and ketone readings. The company recently showcased the device during the American Diabetes Association's Scientific Sessions. Ford declined to provide a timeline or pricing details for the planned device. BTIG analyst Marie Thibault wrote in June that Abbott's management expects a launch sometime next year. The company is also partnering with insulin pump companies, including Tandem, Sequel Med Tech and Beta Bionics, to support the new sensor. 'I think this is going to be a real next-level, significant change in the CGM market,' Ford said, specifically for intensive insulin users. Abbott's electrophysiology business, with the company's new Volt pulsed field ablation device to treat cardiac arrhythmias, grew by 11.5% to $700 million. Recommended Reading 'We are not rolling over': J&J electrophysiology unit rebounds amid PFA rivalry Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Stefani Du Toit is fighting HIV/Aids stigma
Stefani Du Toit is fighting HIV/Aids stigma

News24

time5 hours ago

  • News24

Stefani Du Toit is fighting HIV/Aids stigma

Stefani du Toit is a doer. The 33-year-old has dedicated her adult years to working in the public healthcare sector. 'My work strongly stems from trying to make a positive impact [on] those in a more vulnerable situation,' she told News24. Du Toit is a researcher at the Institute for Life Course Health Research and holds a PhD from Stellenbosch University. Her primary research focuses on substance use and chronic conditions, with a specific focus on HIV and treatment adherence. The 33-year-old's work specialises in adolescent mental health with research spanning seven African countries. She has contributed to developing World Health Organisation guidelines on mental health promotion and preventive interventions for adolescents. Most recently, she received funding from the Faculty of Medicine and Health Sciences' Early Career Research Fund for work on refugee populations.

Slawn Teases Modified Rolex Day-Date
Slawn Teases Modified Rolex Day-Date

Hypebeast

time6 hours ago

  • Hypebeast

Slawn Teases Modified Rolex Day-Date

Summary Olaolu Slawn is on a roll. 2025 has been a busy year for the Nigerian-British artist who's taken overWembley Stadium, an on-track F1 car, Marni's Fall/Winter 2025runwayand anAir Max 90 drop. Following on momentum of the first half of the year, the artist recently took to Instagram to tease the bespokeRolexhe's got in the works. Initial photos of the watch surfaced last week viaClint419onXwho wrote,'SLAWN ROLEX. COMING SOON,'which was followed by a more in-depth look posted by the artist himself. The video shows the Corteiz founder handling what appears to be a customized Italian Oyster PerpetualDay-Date, featuring one of Slawn's signature clown motif on the dial, with a background that boasts peach tones and magenta accents, all framed in classic gold hardware. Last year, Rolex enlisted Slawn for a special 10-piece run of the Datejust 41mm, seen on the wrists of Stormzy, Lil Yachty and Dave. His latestInstagramcaption hints at an'AUGUST 2025'release, though a recentcommentfrom the brand suggests the Day-Date may be a one-of-one. Whether it's a one-off horological work or something more, head to the artist's page for more updates.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store